- Reverse split ratio: 100:1, i.e. one hundred (100) old shares give one (1) new share
-
Date on which the corporate action was made public:
30 April 2024 -
Date of approval:
23 May 2024 (AGM) -
Last day including right:
29 May 2024 (trading inclusive right of reverse split) -
Ex-date:
30 May 2024 (trading exclusive right of reverse split) -
Record date:
31 May 2024 - New number of shares outstanding after reverse share split: 39,087,116
In connection with the reverse share split, the Company's shares will be transferred to a new ISIN.
Please note the following key information for the change of ISIN:
- Issuer:
BerGenBio ASA - Previous ISIN: NO 001 0650013
- New ISIN: NO 001 3251173
-
Date of ISIN change:
30 May 2024
For further information, please contact:
ir@bergenbio.no
rune.skeie@bergenbio.com
About
This information is published in accordance with the requirements of the Continuing Obligations pursuant to Oslo Rule Book II.
https://news.cision.com/bergenbio-asa/r/bergenbio-asa---key-information-relating-to-the-reverse-share-split-and-change-of-isin,c3989709
(c) 2024 Cision. All rights reserved., source